ERBB2 and breast cancer: <b>Background/Objectives</b>: To investigate and develop a non-invasive parametric radiomics model derived from dynamic contrast-enhanced MRI (DCE-MRI) time-intensity curve (TIC) kinetics for predicting breast cancer molecular subtypes (HR+/HER2-, HER2+ and triple-negative breast cancer).